Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.310
-0.090 (-6.43%)
At close: Nov 20, 2024, 4:00 PM
1.319
+0.009 (0.67%)
After-hours: Nov 20, 2024, 4:03 PM EST
Alzamend Neuro Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Selling, General & Admin | 3.08 | 3.48 | 7.42 | 7.12 | 3.64 | 3.35 | |
| Research & Development | 4.3 | 6.46 | 7.45 | 5.2 | 1.31 | 1.07 | |
| Operating Expenses | 7.37 | 9.94 | 14.87 | 12.32 | 4.95 | 4.42 | |
| Operating Income | -7.37 | -9.94 | -14.87 | -12.32 | -4.95 | -4.42 | |
| Interest Expense | -0.02 | -0.01 | -0.01 | -0.05 | -0.16 | - | |
| Interest & Investment Income | - | - | - | - | 0 | 0.01 | |
| EBT Excluding Unusual Items | -7.39 | -9.95 | -14.88 | -12.37 | -5.11 | -4.41 | |
| Other Unusual Items | - | - | - | 0 | 0.06 | - | |
| Pretax Income | -7.39 | -9.95 | -14.88 | -12.36 | -5.05 | -4.41 | |
| Net Income | -7.39 | -9.95 | -14.88 | -12.36 | -5.05 | -4.41 | |
| Net Income to Common | -7.39 | -9.95 | -14.88 | -12.36 | -5.05 | -4.41 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 8.47% | 4.07% | 9.45% | 22.64% | 1.96% | 21.09% | |
| EPS (Basic) | -10.46 | -14.70 | -22.89 | -20.81 | -10.42 | -9.28 | |
| EPS (Diluted) | -10.46 | -14.70 | -22.89 | -20.81 | -10.42 | -9.28 | |
| Free Cash Flow | -6.12 | -8.42 | -8.92 | -6.72 | -2.71 | -2.35 | |
| Free Cash Flow Per Share | -8.65 | -12.44 | -13.73 | -11.31 | -5.60 | -4.94 | |
| EBITDA | -7.32 | -9.89 | -14.85 | -12.32 | - | - | |
| D&A For EBITDA | 0.05 | 0.05 | 0.02 | 0 | - | - | |
| EBIT | -7.37 | -9.94 | -14.87 | -12.32 | -4.95 | -4.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.